Holdings of Bellevue Group AG
143 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 43.2 % of the equity sleeve
Sector breakdown
- Health care 51.7 %
- Industrials 3.3 %
- Technology 0.3 %
- Energy 0.1 %
- Unattributed 44.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 94.1 %
- NL 5.6 %
- IL 0.2 %
- DE 0.0 %
- GB 0.0 %
- KY 0.0 %
- BE 0.0 %
- DK 0.0 %
- FR 0.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 133 | 3.8B $ | 94.09 % |
| 2 | NL | 1 | 228.6M $ | 5.60 % |
| 3 | IL | 1 | 7.5M $ | 0.18 % |
| 4 | DE | 1 | 1.9M $ | 0.05 % |
| 5 | GB | 2 | 1.5M $ | 0.04 % |
| 6 | KY | 2 | 974.4K $ | 0.02 % |
| 7 | BE | 1 | 524.5K $ | 0.01 % |
| 8 | DK | 1 | 122.6K $ | 0.00 % |
| 9 | FR | 1 | 116.7K $ | 0.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 101 | Cytokinetics Inc | 8,841 | 582.7K $ | |
| 102 | Certara Inc | 99,442 | 566.8K $ | |
| 103 | Praxis Precision Medicines Inc | 1,757 | 566.1K $ | |
| 104 | Procter & Gamble Co/The | 3,900 | 563.3K $ | |
| 105 | Mastercard Inc | 1,100 | 549.6K $ | |
| 106 | Cencora Inc | 1,716 | 539.1K $ | |
| 107 | Axsome Therapeutics Inc | 3,181 | 537.7K $ | |
| 108 | VanEck Gold Miners ETF/USA | 5,750 | 527.7K $ | |
| 109 | AGOMAB THERAPEUTICS SA | 50,000 | 524.5K $ | |
| 110 | Blackrock Inc | 450 | 432.8K $ | |
| 111 | Visa Inc | 1,400 | 423.1K $ | |
| 112 | CENTESSA PHARMACEUTICALS PLC | 9,030 | 358.7K $ | |
| 113 | Denali Therapeutics Inc | 17,766 | 341.1K $ | |
| 114 | Structure Therapeutics Inc | 6,803 | 327.9K $ | |
| 115 | JD.COM INC | 11,000 | 325.3K $ | |
| 116 | Summit Therapeutics Inc | 15,858 | 300.7K $ | |
| 117 | Adobe Inc | 1,200 | 291.7K $ | |
| 118 | Amazon.com Inc | 1,353 | 281.8K $ | |
| 119 | Travere Therapeutics Inc | 8,899 | 264.4K $ | |
| 120 | Halozyme Therapeutics Inc | 3,857 | 249.3K $ | |
| 121 | Olema Pharmaceuticals Inc | 16,443 | 245.2K $ | |
| 122 | Tempus AI Inc | 4,950 | 223.8K $ | |
| 123 | Cardinal Health, Inc. | 863 | 182.4K $ | |
| 124 | PTC Therapeutics Inc | 1,935 | 131.8K $ | |
| 125 | IQVIA Holdings Inc | 740 | 126.2K $ | |
| 126 | Ascendis Pharma A/S | 536 | 122.6K $ | |
| 127 | Abivax SA | 1,048 | 116.7K $ | |
| 128 | Caris Life Sciences Inc | 6,418 | 114.8K $ | |
| 129 | Arrowhead Pharmaceuticals Inc | 1,545 | 96.9K $ | |
| 130 | Alphabet Inc | 314 | 90.3K $ | |
| 131 | Rhythm Pharmaceuticals Inc | 1,016 | 88.4K $ | |
| 132 | Agilent Technologies Inc | 664 | 75.7K $ | |
| 133 | Labcorp Holdings Inc | 280 | 74.7K $ | |
| 134 | NVIDIA Corp | 408 | 71.2K $ | |
| 135 | Microsoft Corp | 172 | 63.7K $ | |
| 136 | Zoetis Inc | 533 | 63K $ | |
| 137 | BridgeBio Oncology Therapeutics Inc | 6,982 | 62.5K $ | |
| 138 | Incyte Corp | 486 | 45.7K $ | |
| 139 | Mettler-Toledo International Inc | 36 | 45.4K $ | |
| 140 | Oracle Corp | 191 | 28.1K $ | |
| 141 | Quest Diagnostics Inc | 131 | 25.7K $ | |
| 142 | QUALCOMM Inc | 197 | 25.4K $ | |
| 143 | Recursion Pharmaceuticals Inc | 4,627 | 14.2K $ | |